DZ
Insider
Donald A Zakrowski
SVP, Finance, & CAODonald A Zakrowski (SVP, Finance, & CAO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Eli Lilly and Company (LLY). The largest single filing was $2.4M of LLY (2,000 sh × $1,185.01, as filed), executed Aug 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.4M
shares × price, as filed
Last traded
Aug 10
Filed Aug 11
Median ADV $3.8B across their filed names
Open performance→Volume by month
Buys $0
Sells $6.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
LLYRecent filings
LLYSALE
Eli Lilly and Company
View filing →
$2.4M2,000 sh × $1,185.01
Exec Aug 10
Filed Aug 11 · 4:31 PM ET LLYSALE Eli Lilly and Company View filing → $1.0M
1,000 sh × $1,010.50
Exec Nov 13 2025
Filed Nov 13 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $735K
1,000 sh × $734.93
Exec Aug 28 2025
Filed Aug 28 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $716K
1,000 sh × $716.41
Exec May 27 2025
Filed May 27 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $818K
1,000 sh × $818.24
Exec Mar 13 2025
Filed Mar 13 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $723K
900 sh × $803.38
Exec Nov 8 2024
Filed Nov 8 2024 · 5:30 PM ET